started · updated
Antimicrobial resistance poses growing global health threat
A recent World Health Organization report reveals that one in six common bacterial infections worldwide were resistant to antibiotic treatment in 2023. The data, drawn from over 23 million laboratory-confirmed infections across 104 countries, shows that resistance increased in over 40% of monitored pathogen-antibiotic combinations between 2018 and 2023.
The burden is disproportionately high in the South-East Asian, Eastern Mediterranean, and African regions. In parts of Africa, resistance to third-generation cephalosporins, a primary treatment for serious infections, exceeds 70%. Research published in The Lancet estimated that 4.71 million deaths were associated with bacterial antimicrobial resistance in 2021, with 1.14 million deaths directly attributable to it.
In response to rising resistance to last-resort drugs like colistin, researchers in China have reported a potential breakthrough. A study published in Microbiology Spectrum suggests that combining colistin with the amino acid L-arginine can restore sensitivity in bacteria carrying resistance genes. In animal studies, this combination successfully treated infections by altering bacterial cell membranes to allow the antibiotic to enter and kill the pathogen.
Entities
Microbiology Spectrum · Sun Yat-sen University · The Lancet · World Health Organization